Jingjing Zhao

Jingjing Zhao

Auto-generated profile, based on publicly available information

Jingjing Zhao

Department of Intensive Care Medicine, Hefei No. 2 People Hospital, Hefei 230000, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2019 in Current Gene Therapy
Verified
Journal Article
Closed access
PDF file
JZJingjing Zhao
Jingjing Zhao
TSTianle Sun
Tianle Sun
SWShengdi Wu
Shengdi Wu
YLYufeng Liu
Yufeng Liu
High mobility group box 1 (HMGB1) presents in almost all somatic cells as a component of the cell nucleus. It is necessary for transcription regulation during cell development. Recent studies indicate that extracellular HMGB1, coming from necrotic cells or activated immune cells, triggers inflammatory response whereas intracellular HMGB1 controls the balance between autophagy and apoptosis. In addition, reduced HMGB1 can effectively mediate tissue regeneration. HMGB1, therefore, is regarded as a therapeutic target for inflammatory diseases. In this review, we summarized and discussed the immunomodulatory effect of HMGB1.